Aurora Cannabis (ACB) Change in Account Payables (2021 - 2022)

Aurora Cannabis (ACB) posted quarterly Change in Account Payables of -$721968.9 for Q4 2022, down 125.8% year-on-year from $2.8 million in Q4 2021, and up 74.94% on a QoQ basis from -$2.9 million in Q3 2022.

Aurora Cannabis (ACB) Change in Account Payables (2021 - 2022) Analysis & Trends

Aurora Cannabis (ACB) has reported Change in Account Payables for 2 consecutive years, with -$721968.9 the latest figure, recorded in Q4 2022.

  • Quarterly Change in Account Payables fell 125.8% year-over-year to -$721968.9 in Q4 2022, while the trailing twelve-month figure through Dec 2022 was -$1.7 million (changed N/A YoY) and the FY2023 annual result came in at $11835.1, changed N/A from the prior year.
  • Change in Account Payables grew to -$721968.9 in Q4 2022 per ACB's latest filing, from -$2.9 million in the prior quarter.
  • Over the last five years, Change in Account Payables for ACB reached as high as $2.8 million in Q4 2021 and fell as low as -$2.9 million in Q3 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 62.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 30.60 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 32.70 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Aurora Cannabis 1.11 Bn 1.03 Bn 21.72 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2022 -721,968.88
Dec 31, 2022 -721,968.88
Sep 30, 2022 -2.88 Mn
Sep 30, 2022 -2.88 Mn
Jun 30, 2022 -905,913.46
Jun 30, 2022 -905,913.46
Dec 31, 2021 2.80 Mn
Dec 31, 2021 2.80 Mn
Sep 30, 2021 -2.07 Mn
Sep 30, 2021 -2.07 Mn